• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Enzo Laboratories

Anonymous board for Enzo Laboratories
KC
Replies
72
Views
5K
Replies
41
Views
8K
Replies
32
Views
3K
anonymous
VF
Replies
39
Views
5K
anonymous
Replies
22
Views
1K
anonymous
Replies
5
Views
1K
anonymous
Replies
14
Views
546
anonymous
Replies
120
Views
10K
anonymous
Replies
214
Views
15K
anonymous
Replies
46
Views
4K
anonymous
Replies
1
Views
268
anonymous
Replies
34
Views
2K
anonymous
Replies
3
Views
951
anonymous
VF
Replies
65
Views
5K
anonymous
Replies
9
Views
2K
anonymous
Replies
2
Views
899
anonymous
Replies
2
Views
1K
anonymous
Replies
38
Views
3K
anonymous
Replies
6
Views
1K
anonymous
Replies
6
Views
1K
anonymous